Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Urinary Incontinence 1Rectal Neoplasms 1Prostatic Neoplasms 1Fecal Incontinence 1

Interventions

Cyclophosphamide 909Carboplatin 787pembrolizumab 744Paclitaxel 742Cisplatin 709Bevacizumab 706Gemcitabine 619Docetaxel 579Rituximab 548Radiotherapy 541Dexamethasone 511Nivolumab 488Doxorubicin 444Fluorouracil 392Capecitabine 376Etoposide 358Pemetrexed 337Cytarabine 335Oxaliplatin 333Lenalidomide 328Prednisone 326fludarabine phosphate 316Erlotinib Hydrochloride 314Trastuzumab 300Leucovorin 299fludarabine 296Vincristine 287Filgrastim 284Bortezomib 284Cetuximab 276

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Has results × Biofeedback, Psychology × Clear all
NCT00515853 2022-03-07

The Role of Biofeedback in Improving Continence After Anterior Resection

University of Southampton

Phase NA Completed
121 enrolled 9 charts
Gastrointestinal

Fecal Incontinence, Rectal Neoplasms

NCT00212264 2016-04-11

Conservative Treatment of Postprostatectomy Incontinence

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Phase NA Completed
208 enrolled 9 charts
Genitourinary

Prostatic Neoplasms, Urinary Incontinence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡